Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Rises By 225.0%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 52,000 shares, a growth of 225.0% from the November 15th total of 16,000 shares. Based on an average trading volume of 273,600 shares, the short-interest ratio is currently 0.2 days.

Biodexa Pharmaceuticals Trading Down 5.2 %

Shares of NASDAQ:BDRX traded down $0.23 during trading on Friday, hitting $4.20. 14,328 shares of the company’s stock were exchanged, compared to its average volume of 148,968. The firm has a 50-day moving average of $5.38. Biodexa Pharmaceuticals has a 52-week low of $3.50 and a 52-week high of $81.03.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.